Computer-Aided Detection Market Report 2026

The computer-aided detection market size has grown strongly in recent years. It will grow from $1.08 billion in 2025 to $1.18 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to increasing volume of medical imaging procedures, rising cancer screening programs, expansion of radiology departments, improvements in digital imaging technologies, availability of large annotated imaging datasets.

The computer-aided detection market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2030 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing demand for early and accurate diagnosis, rising adoption of ai-driven clinical decision support, expansion of precision medicine initiatives, growing investments in healthcare ai solutions, increasing regulatory approvals for cad systems. Major trends in the forecast period include increasing use of AI-based image analysis tools, rising adoption of cad in oncology screening, growing integration of cad with imaging modalities, expansion of multi-modal diagnostic platforms, enhanced focus on early disease detection.

The rising prevalence of breast cancer is expected to drive the growth of the computer-aided detection (CAD) market going forward. Breast cancer is a malignant tumor that develops in the breast cells, most often originating in the ducts or lobules, and can spread to surrounding tissues or other parts of the body if not detected and treated early. The increasing rates of breast cancer are largely attributed to lifestyle changes, such as higher obesity levels, which elevate estrogen and may promote tumor growth. Computer-aided detection enhances breast cancer diagnosis by analyzing medical images to identify potential abnormalities, enabling earlier and more accurate detection. CAD assists radiologists in spotting tumors that might otherwise be missed, thereby improving screening accuracy. For example, in October 2024, according to the American Cancer Society, a US-based cancer organization, the number of new invasive breast cancer cases among US women reached approximately 310,720, while ductal carcinoma in situ (DCIS) diagnoses rose to 56,500. Furthermore, in October 2025, according to Breastcancer.org, a US-based nonprofit research and awareness organization, an estimated 316,950 women in the United States will be diagnosed with invasive breast cancer, with an additional 59,080 new DCIS cases, and roughly 42,170 women are projected to die from the disease. Breast cancer continues to represent about 32% of all new cancer cases among US women annually. Therefore, the rising prevalence of breast cancer is driving the growth of the computer-aided detection market.

Key companies in the computer-aided detection market are focusing on developing advanced solutions such as artificial intelligence (AI)-powered CAD software to improve diagnostic accuracy, streamline image analysis, and support early disease detection. AI-powered CAD software utilizes artificial intelligence to scan medical images for potential abnormalities, enhancing precision and assisting in early diagnosis of conditions like cancer. For example, in March 2025, Align Technology, Inc., a Switzerland-based provider of digital orthodontics and restorative dentistry, launched Align X-ray Insights for dental radiograph analysis. The AI-driven software improves dental imaging analysis for more accurate diagnostics and enhances workflow efficiency by delivering real-time insights directly within existing imaging systems, supporting dental professionals in providing precise and timely patient care across the EU and UK.

In June 2023, Olympus Corporation, a Japan-based provider of medical and surgical equipment, acquired Odin Vision for $75.31 million. This acquisition strengthens Olympus’s position in digital health by integrating Odin Vision’s advanced AI capabilities into its endoscopy portfolio, improving the precision and efficiency of diagnostic procedures. The move highlights Olympus’s commitment to innovation and advancing healthcare through transformative technology. Odin Vision is a UK-based cloud-AI endoscopy company offering computer-aided detection and diagnostic solutions.

Major companies operating in the computer-aided detection market are Hitachi Ltd., IBM, Fujifilm Holdings Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Hologic Inc., Canon Medical Systems Corporation, Agfa‑Gevaert NV, Carestream Health Inc., ESAOTE S.p.A., Aidoc Medical Ltd., Median Technologies S.A., iCAD Inc., Riverain Technologies LLC, Zebra Medical Vision Ltd., CureMetrix Inc., THERAPIXEL S.A.S., ScreenPoint Medical B.V., Lunit Inc., Qure.ai, Delft Imaging, VinBrain.

North America was the largest region in the computer-aided detection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the computer-aided detection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the computer-aided detection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the computer-aided detection market by increasing costs of imported imaging hardware components, graphics processors, data servers, and specialized software systems required for AI-driven analysis. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported high-performance computing infrastructure, while Asia-Pacific faces higher costs in CAD software deployment. These tariffs are increasing system acquisition costs and slowing upgrade cycles. However, they are also encouraging domestic software development, localized system integration, and regional innovation in AI-based diagnostic solutions.

The computer-aided detection market research report is one of a series of new reports that provides computer-aided detection market statistics, including computer-aided detection industry global market size, regional shares, competitors with a computer-aided detection market share, detailed computer-aided detection market segments, market trends and opportunities, and any further data you may need to thrive in the computer-aided detection industry. This computer-aided detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Computer-aided detection (CAD) is a medical imaging technology that utilizes algorithms and artificial intelligence (AI) to analyze scans and identify potential abnormalities, such as tumors or fractures. It functions as a supportive tool for radiologists, providing a second opinion to facilitate early and accurate diagnosis. By enhancing detection accuracy and reducing missed findings, CAD improves overall diagnostic reliability.

The primary products of computer-aided detection include mammography, ultrasound imaging, magnetic resonance imaging, tomosynthesis, computed tomography, and others. Mammography employs low-dose X-rays combined with CAD to detect early signs of breast cancer and other abnormalities with greater precision. CAD is applied across various medical indications, including tuberculosis, breast cancer, lung cancer, colon cancer, prostate cancer, liver cancer, bone cancer, and neurological disorders. Key end users include hospitals, clinics, diagnostic centers, and other healthcare facilities.

The computer-aided detection market consists of revenues earned by entities by providing services such as medical image analysis, diagnosis assistance, data management and reporting, and pre-screening support. The market value includes the value of related goods sold by the service provider or included within the service offering. The computer-aided detection market also includes sales of nuclear medicine imaging systems, endoscopy-based computer-aided detection systems, and dermoscopic imaging computer-aided detection systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.